Approved with 99.89% support, the proposal updates issuance and buyback parameters that govern how INJ is removed from circulation over time. Injective’s protocol community approved a major tokenomics ...
AAV-based gene therapies hold promise for treating disease, but their long-lasting gene expression limits their use in regenerative medicine. A study now presents DreAM, a drug-inducible AAV system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback